Connect
MJA
MJA

Complementary medicine use in cardiovascular disease: a clinician’s viewpoint

Hosen Kiat, Yu Sun Bin, Suzanne Grant and Dennis Hsu-Tung Chang
Med J Aust 2011; 195 (11): 654-656. || doi: 10.5694/mja10.10976
Published online: 12 December 2011

Patients with cardiovascular disease may be especially prone to the adverse effects of complementary medicines

Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in Australia.1 Given the chronic nature of CVD, medical management is the most common mode of care, and medications are prescribed to most patients with CVD.2 In general practice, treatment of CVD accounts for almost one in five encounters, with hypertension the most commonly treated risk factor, followed by lipid disorders.2

  • Hosen Kiat1
  • Yu Sun Bin2
  • Suzanne Grant3
  • Dennis Hsu-Tung Chang3

  • 1 Australian School of Advanced Medicine, Macquarie University, Sydney, NSW.
  • 2 Cardiac Health Institute, Sydney, NSW.
  • 3 Centre for Complementary Medicine Research, University of Western Sydney, Sydney, NSW.

Correspondence: hosen.kiat@chi.org.au

Acknowledgements: 

We thank Lisa Wallis for assistance in manuscript preparation.

Competing interests:

No relevant disclosures.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.